Physician profile
Lanelle N Lapig
NPI 1114666765
$1,634.60
in general payments reported to CMS, 2019-2025
17 companies · $563 in 2025
The $563 reported for 2025 was more than what 83% of Community Health (Nurse Practitioner) providers received nationally (typical 2025 total: $139).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $106 · 2023: $803 · 2024: $162 · 2025: $563.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,528.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,528.43 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kowa Pharmaceuticals America, INC. | $381.89 | 2024-2025 | Zoryve |
| Merck Sharp & Dohme LLC | $182.54 | 2022-2023 | Gardasil 9, Vaxelis, Rotateq |
| Regeneron Healthcare Solutions, INC. | $161.75 | 2023 | Dupixent |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $148.79 | 2023 | |
| Dexcom, INC. | $147.30 | 2022-2023 | Dexcom G6 Transmitter |
| Lilly USA, LLC | $117.12 | 2022-2025 | Mounjaro, Zepbound |
| Cranial Technologies, INC | $91.62 | 2023-2025 | Doc Band |
| Amgen INC. | $84.70 | 2024-2025 | Otezla, Repatha, Otezla |
| Novo Nordisk INC | $77.19 | 2022-2025 | Wegovy |
| Abbvie INC. | $41.43 | 2023-2024 | |
| Pfizer INC. | $40.68 | 2023-2024 | |
| Bayer Healthcare Pharmaceuticals INC. | $39.75 | 2025 | |
| Exact Sciences Corporation | $37.11 | 2023-2024 | Cologuard Collection Kit |
| Aurinia Pharma U.S., INC. | $26.59 | 2023 | Lupkynis |
| Hologic Sales and Service, LLC | $24.27 | 2023 | Aptima, Thinprep 2000 Processor |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Becton, Dickinson and Company | $17.28 | 2023 | Bd Onclarity |
| Mayne Pharma Commercial LLC | $14.59 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lanelle Lapig listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.